Logo image of TACT

TRANSACT TECHNOLOGIES INC (TACT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TACT - US8929181035 - Common Stock

4.03 USD
0 (0%)
Last: 1/16/2026, 8:00:01 PM
Fundamental Rating

4

Overall TACT gets a fundamental rating of 4 out of 10. We evaluated TACT against 35 industry peers in the Technology Hardware, Storage & Peripherals industry. No worries on liquidiy or solvency for TACT as it has an excellent financial health rating, but there are worries on the profitability. TACT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • TACT had negative earnings in the past year.
  • TACT had a positive operating cash flow in the past year.
  • TACT had negative earnings in 4 of the past 5 years.
  • In multiple years TACT reported negative operating cash flow during the last 5 years.
TACT Yearly Net Income VS EBIT VS OCF VS FCFTACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • TACT's Return On Assets of -17.93% is on the low side compared to the rest of the industry. TACT is outperformed by 62.86% of its industry peers.
  • TACT's Return On Equity of -25.38% is in line compared to the rest of the industry. TACT outperforms 54.29% of its industry peers.
Industry RankSector Rank
ROA -17.93%
ROE -25.38%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
TACT Yearly ROA, ROE, ROICTACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

  • TACT has a better Gross Margin (47.93%) than 85.71% of its industry peers.
  • TACT's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for TACT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
TACT Yearly Profit, Operating, Gross MarginsTACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

7

2. Health

2.1 Basic Checks

  • TACT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TACT has been increased compared to 1 year ago.
  • Compared to 5 years ago, TACT has more shares outstanding
  • Compared to 1 year ago, TACT has a worse debt to assets ratio.
TACT Yearly Shares OutstandingTACT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
TACT Yearly Total Debt VS Total AssetsTACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • TACT has an Altman-Z score of 3.71. This indicates that TACT is financially healthy and has little risk of bankruptcy at the moment.
  • TACT's Altman-Z score of 3.71 is fine compared to the rest of the industry. TACT outperforms 71.43% of its industry peers.
  • TACT has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.38, TACT belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
  • TACT has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • TACT has a Debt to Equity ratio of 0.09. This is in the better half of the industry: TACT outperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.38
Altman-Z 3.71
ROIC/WACCN/A
WACC8.85%
TACT Yearly LT Debt VS Equity VS FCFTACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 3.05 indicates that TACT has no problem at all paying its short term obligations.
  • TACT's Current ratio of 3.05 is amongst the best of the industry. TACT outperforms 82.86% of its industry peers.
  • TACT has a Quick Ratio of 2.14. This indicates that TACT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.14, TACT belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 2.14
TACT Yearly Current Assets VS Current LiabilitesTACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 65.00% over the past year.
  • Looking at the last year, TACT shows a quite strong growth in Revenue. The Revenue has grown by 8.27% in the last year.
  • Measured over the past years, TACT shows a decrease in Revenue. The Revenue has been decreasing by -1.06% on average per year.
EPS 1Y (TTM)65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)8.27%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%21.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.01% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, TACT will show a quite strong growth in Revenue. The Revenue will grow by 13.13% on average per year.
EPS Next Y55.12%
EPS Next 2Y34.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TACT Yearly Revenue VS EstimatesTACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
TACT Yearly EPS VS EstimatesTACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • TACT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TACT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TACT Price Earnings VS Forward Price EarningsTACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • 97.14% of the companies in the same industry are more expensive than TACT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.09
EV/EBITDA N/A
TACT Per share dataTACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • TACT's earnings are expected to grow with 34.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.01%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for TACT!.
Industry RankSector Rank
Dividend Yield 0%

TRANSACT TECHNOLOGIES INC

NASDAQ:TACT (1/16/2026, 8:00:01 PM)

4.03

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-10
Earnings (Next)03-11
Inst Owners57.88%
Inst Owner Change0%
Ins Owners3.43%
Ins Owner Change1.19%
Market Cap40.74M
Revenue(TTM)50.26M
Net Income(TTM)-8.07M
Analysts82.86
Price Target5.1 (26.55%)
Short Float %0.19%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.2%
Min EPS beat(2)80.39%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)79.62%
Min EPS beat(4)38.08%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)66.65%
EPS beat(12)12
Avg EPS beat(12)261.46%
EPS beat(16)15
Avg EPS beat(16)199.46%
Revenue beat(2)1
Avg Revenue beat(2)3.2%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)7.79%
Revenue beat(4)2
Avg Revenue beat(4)4.77%
Min Revenue beat(4)-3.25%
Max Revenue beat(4)15.92%
Revenue beat(8)3
Avg Revenue beat(8)0.47%
Revenue beat(12)7
Avg Revenue beat(12)3.49%
Revenue beat(16)10
Avg Revenue beat(16)4.99%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)26.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.81
P/FCF 5.09
P/OCF 4.31
P/B 1.28
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.79
FCFY19.64%
OCF(TTM)0.93
OCFY23.2%
SpS4.97
BVpS3.14
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.93%
ROE -25.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.93%
FCFM 15.92%
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.38
Debt/EBITDA N/A
Cap/Depr 207.43%
Cap/Sales 2.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.05
Quick Ratio 2.14
Altman-Z 3.71
F-Score4
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)63.1%
Cap/Depr(5y)77.66%
Cap/Sales(3y)1.41%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y55.12%
EPS Next 2Y34.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.27%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%21.25%
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y57.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.79%
FCF growth 3YN/A
FCF growth 5Y-15.06%
OCF growth 1Y43.65%
OCF growth 3YN/A
OCF growth 5Y-17.43%

TRANSACT TECHNOLOGIES INC / TACT FAQ

What is the ChartMill fundamental rating of TRANSACT TECHNOLOGIES INC (TACT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TACT.


Can you provide the valuation status for TRANSACT TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 2 / 10 to TRANSACT TECHNOLOGIES INC (TACT). This can be considered as Overvalued.


How profitable is TRANSACT TECHNOLOGIES INC (TACT) stock?

TRANSACT TECHNOLOGIES INC (TACT) has a profitability rating of 2 / 10.


How sustainable is the dividend of TRANSACT TECHNOLOGIES INC (TACT) stock?

The dividend rating of TRANSACT TECHNOLOGIES INC (TACT) is 0 / 10 and the dividend payout ratio is 0%.